Similar to the results obtained in cell lines, STK3 knock-down showed significant reduction in the percentage of GFP positive cells compared to cells expressing control shRNA, in some but not in all AML patient samples (Figure 3B). Here, STK3 is linked to acute myeloid leukemia.